Ewa Wawrzyniak

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta et al. · European Journal Of Haematology · 2007 · 143 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Agata Wrzesień‐Kuś, Tadeusz Robak, Agnieszka Wierzbowska et al. · Annals of Hematology · 2005 · 42 citations

Medicine, Oncology, Pharmacology +15

<i>CD38</i>Gene Polymorphisms Contribute to Genetic Susceptibility to B-Cell Chronic Lymphocytic Leukemia: Evidence from Two Case-Control Studies in Polish Caucasians

Krzysztof Jamroziak, Zofia Szemraj, Olga Grzybowska‐Izydorczyk et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 32 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

Paweł Robak, Edyta Węgłowska, Izabela Dróźdż et al. · Mediators of Inflammation · 2020 · 30 citations · Full text

Medicine, Immunology, Pharmacology +14

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion

Tadeusz Robak, Jerzy Z. Błoński, Ewa Wawrzyniak et al. · Cancer · 2008 · 26 citations

Medicine, Oncology, Pharmacology +15